首页> 外文OA文献 >Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial

【2h】

Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial

机译：在移植型无肢体瘤中的诱导和维持过程中优化免疫调节药物的价值：骨髓瘤XI，多期，开放标签，随机，第三阶段试验的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Graham H. Jackson; Charlotte Pawlyn; David A. Cairns; Alina Striha; Corinne Collett; Anna Waterhouse; John R. Jones; Jamie Wilson; Craig Taylor; Bhuvan Kishore; Mamta Garg; Cathy D. Williams; Kamaraj Karunanithi; Jindriska Lindsay; Matthew W. Jenner; Gordon Cook; Nigel H. Russell; Mark T. Drayson; Martin F. Kaiser; Roger G. Owen; Walter M. Gregory; Faith E. Davies; Gareth J. Morgan;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial [J] . Jackson Graham H., Davies Faith E., Pawlyn Charlotte, The lancet oncology . 2019,第1期

机译：新诊断的多骨瘤患者的Lenalidomide维持对观察（骨髓瘤XI）：多期，开放标签，随机，第3阶段试验
2. Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial [J] . Perrot Aurore, Facon Thierry, Plesner Torben, Journal of Clinical Oncology . 2021,第3期

机译：在新诊断的多种骨髓瘤患者中有效相关性生活质量：III期MAIA审判的调查结果
3. Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial [J] . Knop Stefan, Mateos Maria-Victoria, Dimopoulos Meletios A., BMC Cancer . 2021,第1期

机译：新诊断的多骨骼患者患者的健康相关质量，无需符合干细胞移植：随机期III alcyone试验的结果
4. Mutation, SNP and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patients. [D] . Onwuazor, Obiageli Nneka. 2003

机译：150名新诊断的多发性骨髓瘤患者的成纤维细胞生长因子受体3（FGFR3）的突变，SNP和同工型分析。
5. Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre open-label randomised phase 3 trial [O] . Graham H Jackson, Faith E Davies, Charlotte Pawlyn, -1

机译：来那度胺维持与观察对新诊断的多发性骨髓瘤（Myeloma XI）患者：一项多中心开放标签随机3期试验
6. Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial [O] . Graham H Jackson, Faith E Davies, Charlotte Pawlyn, 2019

机译：新诊断多种骨髓瘤患者的Lenalidomide维持与观察（骨髓瘤XI）：多期，开放标签，随机，第3阶段试验

Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial

著录项

相似文献

相关主题

期刊订阅